BIO Submits Comments to the Departments of Labor, Treasury, and Health and Human Services on the Request for Information Regarding Provider Nondiscrimination

 

June 10, 2014

 

Jacob J. Lew

Secretary, Department of the Treasury

1500 Pennsylvania Avenue, NW

Washington, D.C. 20220

                             

Thomas E. Perez

Secretary, Department of Labor

Frances Perkins Building, 200 Constitution Ave., NW,

Washington, DC 20210

 

Sylvia Mathews Burwell

Secretary, Department of Health and Human Services

200 Independence Avenue, SW

Washington, DC 20201

 

Re: Request for Information Regarding Provider Nondiscrimination

 

Dear Secretaries Lew, Perez, and Burwell:

 

The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the “Request for Information Regarding Provider Nondiscrimination” (the “RFI”) issued by the Departments of Treasury, Labor, and Health and Human Services (“the Departments”) on March 12, 2014.[1]

 

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO's members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place. In that way, our members’ novel therapeutics, vaccines, and diagnostics not only have improved health outcomes, including productivity and quality of life, but also have reduced health care expenditures due to fewer physician office visits, hospitalizations, and surgical interventions.



[1] 79 Fed. Reg. 14,052 (March 12, 2014).

 

To view the comment letter, click here.